CSIMarket
 
Maia Biotechnology Inc   (MAIA)
 

The company announced operating surplus of $8.53763 millions, in the fourth quarter of 2022 financial report

company delivered fourth quarter of 2022 operating surplus of $8.53763 millions


Published Mar 25 2023
Goran Soko / CSIMarket.com Contributer


pills_blue_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons The Major Pharmaceutical Preparations sector reporters start to digest the fourth quarter of 2022 results. Now those reporters observe operating surplus of $8.53763 millions, from the company, which has not stated any top-line thus far, for the own October to December 31 2022 quarter.




The company resumes to be profitable and actually did advance net profits from $0.000 millions, in the fourth quarter of , to $8.210 millions, in the October to December 31 2022 interval.


Maia Biotechnology Inc is expected to report next financial earnings on August 21, 2023.



Maia Biotechnology Inc's Inventory Turnover Ratio

Maia Biotechnology Inc's Dividend Pay out



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071